While there have been reports of using Mini-dCas13X for Duchenne muscular dystrophy (Li et al., 2023), RNA base editors recruiting endogenous ADAR for diseases with target tissues outside the liver have yet to be tested. The gene discussed is ADAR; the disease is Duchenne muscular dystrophy.